middle.news
Starpharma milestone triggers $0.5 million option fee from Radiopharm
9:29am on Friday 3rd of July, 2026 AEST
•
Biotechnology
Read Story
Starpharma milestone triggers $0.5 million option fee from Radiopharm
9:29am on Friday 3rd of July, 2026 AEST
Key Points
Collaboration milestone triggers $0.5 million option fee
Radiopharm gains option to exclusively license DEP® dendrimer technology
Potential licensing deal worth up to $91 million including milestones and royalties
Milestone follows completion of initial development and manufacturing phases
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Starpharma (ASX:SPL)
OPEN ARTICLE